 |
인쇄하기
취소
|
Stem cells emerge as leading stock
Stem cell-related stocks have come back to the throne as the U.S. President Barack Obama will sign an executive order overturning President’s Bush’s embryonic stem cell research policy, according to Mirae Asset
Stocks of Samjin Pharm and Cho-A Pharm have recorded 11.15 percent and 14.90 percent investment return, respectively, the junior stock market, Kosdaq, these days.
Biopharmaceutical...
Stocks of Samjin Pharm and Cho-A Pharm have recorded 11.15 percent and 14.90 percent investment return, respectively, the junior stock market, Kosdaq, these days.
Biopharmaceutical...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.